CRYO CELL INTERNATIONAL INC
About CRYO CELL INTERNATIONAL INC
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2017
- $25.4M
- Net income
- -$2.4M
- Total assets
- $61.7M
- Market cap
- $28.2M
- Gross margin
- 76.6%
- Operating margin
- 1.5%
- Net margin
- -7.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $31.6M
- Cost of revenue
- $7.4M
- Gross profit
- $24.2M
- Operating expenses
- $23.7M
- Operating income
- $482.4K
- Income tax
- $92.2K
- Net income
- -$2.4M
- EPS (basic)
- $-0.30
- EPS (diluted)
- $-0.30
Balance sheet
- Total assets
- $61.7M
- Current assets
- $11.8M
- Total liabilities
- $80.3M
- Current liabilities
- $19.8M
- Shareholders’ equity
- -$18.6M
Cash flow
- Operating cash flow
- $5.5M
- Investing cash flow
- -$975.3K
- Financing cash flow
- -$4.7M
- Net cash flow
- -$241.9K
Statements via Polygon.io (SEC filings)
- Market cap
- $28.2M
- EPS (diluted)
- $-0.3
- Dividend yield
- 16.35%
- Shares outstanding
- 7.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $2.4M in FY2017.
- Revenue grew 9% from FY2021 to FY2025.
- Gross margin of 76.6%, net margin -7.7%.
- Trading 33% below its 52-week high.
- Pays a dividend yielding about 16.35% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CRYO CELL INTERNATIONAL INC.
Write a review
News about CRYO CELL INTERNATIONAL INC
News & sentiment via Polygon.io
